Intracellica Bio Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $1.61M

  • Investors
  • 3

Intracellica Bio General Information

Description

Developer of antibody therapies designed to treat Alzheimer's disease and other neurodegenerative conditions. The company is currently operating in Stealth Mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Brisbane, Queensland
  • Australia
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Brisbane, Queensland
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intracellica Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 22-Sep-2026 $1.61M Completed Stealth
1. Spin-Off Completed Stealth
To view Intracellica Bio’s complete valuation and funding history, request access »

Intracellica Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
ANDHealth Accelerator/Incubator
Brandon Biocatalyst Venture Capital Minority
Dementia Australia Corporation
To view Intracellica Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Intracellica Bio FAQs

  • Where is Intracellica Bio headquartered?

    Intracellica Bio is headquartered in Brisbane, Australia.

  • What industry is Intracellica Bio in?

    Intracellica Bio’s primary industry is Drug Discovery.

  • Is Intracellica Bio a private or public company?

    Intracellica Bio is a Private company.

  • What is Intracellica Bio’s current revenue?

    The current revenue for Intracellica Bio is .

  • How much funding has Intracellica Bio raised over time?

    Intracellica Bio has raised $1.61M.

  • Who are Intracellica Bio’s investors?

    ANDHealth, Brandon Biocatalyst, and Dementia Australia have invested in Intracellica Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process